- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Nifuroxazide is an antibiotic used to treat a variety of bacterial infections. It belongs to the nitrofuran class of antibiotics and is used to treat gastrointestinal infections, such as traveler's diarrhea, as well as urinary tract infections. Nifuroxazide is also used to treat bacterial infections of the skin, such as impetigo and furunculosis. It is available in both oral and intravenous formulations.
Nifuroxazide is generally well tolerated, with few side effects. Common side effects include nausea, vomiting, and diarrhea. Rare side effects include allergic reactions, such as rash, hives, and difficulty breathing.
Nifuroxazide is available in many countries, including the United States, Canada, and the United Kingdom. It is available in generic form and under various brand names, such as Furazolidone, Furadantin, and Nifuroxazide.
Some companies in the Nifuroxazide market include Pfizer, Merck, GlaxoSmithKline, and Sanofi. Show Less Read more